Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study

European Journal of Clinical Pharmacology

Volumn 61, Issue 5-6, 2005, Pages 445-451

  Maison, Patrick ^a,b   Cunin, Patrick ^a   Hemery, François ^a   Fric, Florence ^a   Elie, Nicole ^c   Del'Volgo, Aldo ^c   Dubois Randé, Jean Luc ^a   Hittinger, Luc ^a   Macquin Mavier, Isabelle ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

^c National Health Insurance Fund   (France)

Author keywords

Drug utilisation; Elderly; Heart failure; Hospitalisation; Pharmacoepidemiology

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SPIRONOLACTONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTPATIENT CARE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CASE-CONTROL STUDIES; DIURETICS; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; SPIRONOLACTONE;

EID: 27644551032     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0939-0     Document Type: Article

References (27)

1. Butler J, Arbogast PG, Daugherty J, Jain MK, Ray WA, Griffin MR (2004) Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 43:2036-2043
2. Cleland JG, Swedberg K, Cohen-Solal A, Cosin-Aguilar J, Dietz R, Follath F et al (2000) The euro heart failure survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The study group on diagnosis of the working group on heart failure of the European society of cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2:123-132
3. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G (2000) A national survey of heart failure in French hospitals. The Myocardiopathy and heart failure working group of the French society of cardiology, the national college of general hospital cardiologists and the French geriatrics society. Eur Heart J 21:763-769
4. Cowie MR (1999) Annotated references in epidemiology. Eur J Heart Fail 1:101-107
5. Cowie MR, Fox KF, Wood DA, Metcalfe C, Thompson SG, Coats AJ et al (2002) Hospitalization of patients with heart failure: a population-based study. Eur Heart J 23:877-885
6. Davis RC, Hobbs FD, Kenkre JE, Roalfe AK, Hare R, Lancashire RJ et al (2002) Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ 325:1156
7. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW et al (2000) Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 35:1628-1637
8. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM (2002) Spectrum of heart failure in older patients: results from the national heart failure project. Am Heart J 143:412-417
9. Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT et al (2004) The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 140:714-720
10. Horwich TB, MacLellan WR, Fonarow GC (2004) Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 43:642-648
11. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS et al (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 38:2101-2113
12. Johnson D, Jin Y, Quan H, Cujec B (2003) Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol 42:1438-1445
13. Ko DT, Mamdani M, Alter DA (2004) Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 291:1864-1870
14. Komajda M, Bouhour JB, Amouyel P, Delahaye F, Vicaut E, Croce I et al (2001) Ambulatory heart failure management in private practice in France. Eur J Heart Fail 3:503-507
15. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A et al (2003) The euro heart failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24:464-474
16. Litaker JR, Chou JY (2003) Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature. Clin Ther 25:1918-1935
17. Node K, Fujita M, Kitakaze M, Hori M, Liao JK (2003) Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 108:839-843
18. Philbin EF, DiSalvo TG (1999) Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol 33:1560-1566
19. Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL (1999) Clinical outcomes in heart failure: report from a community hospital-based registry. Am J Med 107:549-555
20. Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL (2000) Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 109:605-613
21. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM (1995) A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333:1190-1195
22. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR et al (1999) Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 159:29-34
23. Stewart S, Marley JE, Horowitz JD (1999) Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet 354:1077-1083
24. Wattigney WA, Mensah GA, Croft JB (2003) Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 108:711-716
25. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F et al (1999) Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. Epidemiologie de l'insuffisance cardiaque avancee en lorraine. J Am Coll Cardiol 33:734-742
26. Struthers AD, Anderson G, Donnan PT, MacDonald T (2000) Social deprivation increases cardiac hospitalisations in chronic heart failure independent of disease severity and diuretic non-adherence. Heart 83:12-16
27. Philbin EF, Dec GW, Jenkins PL, DiSalvo TG (2001) Socioeconomic status as an independent risk factor for hospital readmission for heart failure. Am J Cardiol 87:1367-1371